Probiotics and GLP-1: Enhancing Weight Loss and Gut Health The rise of GLP-1 receptor agonists—such as semaglutide (Ozempic and Wegovy) and tirzepatide (Mounjaro and Zepbound)—has transformed the treatment of obesity …
Tag:
obesity treatment
-
-
MEDVi has a physician-monitored telehealth platform that enables patients to receive GLP-1 weight loss therapy through linking with licensed clinicians, compounded drugs via licensed pharmacies and formal medical supervision. MEDVi …
-
Weight Loss Jabs: Rapid Regain and the Need for Long-Term Support Table of Contents Weight Loss Jabs: Rapid Regain and the Need for Long-Term Support The Challenge of Weight Regain …
-
WHO Issues Guidelines on GLP-1 Therapies for Obesity Treatment The World health Organization (WHO) has released new guidelines on the use of GLP-1 (glucagon-like peptide-1) receptor agonists for obesity treatment. …
-
Higher Dose of Semaglutide Shows Promise for Weight Loss A higher weekly dose of semaglutide (7.2 mg) can significantly improve weight loss and related health outcomes in adults living with …